Old Web
English
Sign In
Acemap
>
Paper
>
MEK1/2 Inhibition as a Therapeutic Target in an NRAS-Mutated Pediatric Neuroendocrine Tumor
MEK1/2 Inhibition as a Therapeutic Target in an NRAS-Mutated Pediatric Neuroendocrine Tumor
2020
Colin H. Quinn
Adele P. Williams
Raoud Marayati
Hooper R. Markert
Jamie M. Aye
Jerry E. Stewart
Karina J. Yoon
Elizabeth A. Beierle
Keywords:
Neuroblastoma RAS viral oncogene homolog
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]